-
Home
- Publications
Proteasome activator complex PA28 identified as an accessible target in prostate cancer by in vivo selection of human antibodies
Sánchez-Martín D, Martínez-Torrecuadrada J, Teesalu T, Sugahara KN, Alvarez-Cienfuegos A, Ximénez-Embún P, Fernández-Periáñez R, Martín MT, Molina-Privado I, Ruppen-Cañás I, Blanco-Toribio A, Cañamero M, Cuesta AM, Compte M, Kremer L, Bellas C, Alonso-Camino V, Guijarro-Muñoz I, Sanz L, Ruoslahti E, Alvarez-Vallina L
Proc Natl Acad Sci U S A. 2013 Aug 20;110(34):13791-6. doi: 10.1073/pnas.1300013110. Epub 2013 Aug 5
Tumor-penetrating peptides
Teesalu T, Sugahara KN, Ruoslahti E
Front. Oncol., 27 August 2013 | doi: 10.3389/fonc.2013.00216
Sequence dependence of C-end rule peptides in binding and activation of neuropilin-1 receptor
Zanuy D, Kotla R, Nussinov R, Teesalu T, Sugahara KN, Alemán C, Haspel N.
J Struct Biol. 2013 Feb 24. doi:pii: S1047-8477(13)00043-9. 10.1016/j.jsb.2013.02.006. [Epub ahead of print]
The non-peptidic part determines the internalization mechanism and intracellular trafficking of peptide amphiphiles
Missirlis D, Teesalu T, Black M, Tirrell M.
PLoS One. 2013;8(1):e54611. doi: 10.1371/journal.pone.0054611. Epub 2013 Jan 17.
Application of a proapoptotic peptide to intratumorally spreading cancer therapy
Chen R, Braun GB, Luo X, Sugahara KN, Teesalu T, Ruoslahti E.
Cancer Res. 2013 Feb 15;73(4):1352-61. doi: 10.1158/0008-5472.CAN-12-1979. Epub 2012 Dec 17.
De novo design of a tumor-penetrating peptide
Alberici L, Roth L, Sugahara KN, Agemy L, Kotamraju VR, Teesalu T, Bordignon C, Traversari C, Rizzardi GP, Ruoslahti E.
Cancer Res. 2013 Jan 15;73(2):804-12. doi: 10.1158/0008-5472.CAN-12-1668. Epub 2012 Nov 14.
Mapping of vascular ZIP codes by phage display
Teesalu T, Sugahara KN, Ruoslahti E.
Methods Enzymol. 2012;503:35-56. doi: 10.1016/B978-0-12-396962-0.00002-1.
